Medinova Diagnostic Services Ltd vs CIPLA LTD
A side-by-side comparison of Medinova Diagnostic Services Ltd (246883) and CIPLA LTD (CIPLA) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.
Medinova Diagnostic Services Ltd vs CIPLA LTD are evenly matched on the numbers (6–6, 2 undecided). The breakdown below shows where each one wins.
- Valuation22
- Profitability31
- Growth· not comparable—
- Size & financial health13
Valuation
EvenHow expensive each stock is relative to its earnings and book value. Lower usually means cheaper.
Profitability
246883 takes 3/4How efficiently each company turns capital and sales into profit. Higher is better.
Growth
Three-year compounded growth. Faster-growing businesses can justify a higher valuation.
Size & financial health
CIPLA takes 3/4Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.
- − ["The company has delivered a poor sales growth of 5.66% over past five years."]
- + ["Company is almost debt free.", "Company has been maintaining a healthy dividend payout of 25.7%"]
- − ["The company has delivered a poor sales growth of 8.01% over past five years.", "Promoter holding has decreased over last 3 years: -4.24%"]
This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.